Mariner, LLC Neogenomics Inc Transaction History
Mariner, LLC
- $58.4 Billion
- Q4 2024
A detailed history of Mariner, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Mariner, LLC holds 27,817 shares of NEO stock, worth $353,832. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,817
Previous 30,486
8.75%
Holding current value
$353,832
Previous $449,000
2.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$250 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$181 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$83 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$78.4 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$78.3 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.6B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...